To determine if preventing a stroke‐induced loss of immunoglobulins is an effective therapeutic strategy to limit stroke‐associated bacterial pneumonia, animals were given a low dose of IgM‐IVIg (250 mg/kg) prior to experimental stroke induced by transient MCAO or sham surgery and at 24‐h post‐surgery. The gene discussed is CD40LG; the disease is bacterial pneumonia.